Why the study?
Is mild to moderate renal impairment at admission associated with an increased risk of no-reflow phenomenon in STEMI patients treated with primary PCI?
Is mild to moderate renal impairment at admission associated with an increased risk of no-reflow phenomenon in STEMI patients treated with primary PCI?
Mild to moderate renal impairment at admission is an independent predictor of the no-reflow phenomenon in STEMI patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
Renal impairment at admission was associated with higher no-reflow risk in primary PCI; leaves open whether eGFR-guided interventions improve outcomes.
We investigated whether admission estimated glomerular filtration rate (eGFR) values are associated with no-reflow phenomenon in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). Patients (n = 673; 59 ± 13 years; 77.1% men) were stratified into 3 groups according to eGFR at admission: normal renal function (eGFR ≥ 90 mL/min/1.73 m2), mild renal impairment (eGFR 60-89 mL/min/1.73 m2), and moderate renal impairment (eGFR 30-59 mL/min/1.73 m2). No-reflow phenomenon was defined as thrombolysis in myocardial infarction flow grade <3 after pPCI. The rate of no-reflow gradually increased from the normal renal function group to the moderate impaired renal function group (P < .001). Multivariate analysis showed that eGFR (odds ratio [OR] 0.942, P < .001), Killip ≥2 class (OR 3.968, P = .008), left ventricular ejection fraction (OR 0.959, P = .034), and early patency of infarct vessel (OR 0.186, P < .001) were independent predictors of no-reflow phenomenon. Mild to moderate renal impairment at admission is independently associated with no-reflow phenomenon after pPCI.
No takes yet. Share an insight, caveat, or question.
Kurtul et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: